SK Biopharma’s Record Earnings Driven by Strong Xcopri Sales in US Business & Economy SK Biopharma’s Record Earnings Driven by Strong Xcopri Sales in US editor 5월 7, 2026 SK Biopharmaceuticals Achieves Record Q1 Earnings, Driving Global Expansion of Xcopri for Epilepsy Treatment Logo of SK...Read More
